Clínica Alemana

Futó vizsgálatok

• Toboroz

  A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

  NCT07519772· 1/2. fázis· Forrás

• Toboroz

  A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  NCT07463183· 2. fázis· Forrás

• Toboroz

  The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

  NCT07027306· Forrás

• Toboroz

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  NCT07318558· 3. fázis· Forrás

• Toboroz

  The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study

  NCT06839300· Forrás

• Toboroz

  A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

  NCT07222761· 3. fázis· Forrás

• Toboroz

  A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

  NCT06926868· 2/3. fázis· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  NCT07011745· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT06508658· 3. fázis· Forrás

• Fut, nem toboroz

  Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

  NCT06456346· 3. fázis· Forrás

• Toboroz

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· 3. fázis· Forrás

• Toboroz

  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  NCT06091865· 3. fázis· Forrás

• Toboroz

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

  NCT06052059· 3. fázis· Forrás

• Toboroz

  A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT05730036· 3. fázis· Forrás

• Toboroz

  A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  NCT05947851· 3. fázis· Forrás

• Fut, nem toboroz

  Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

  NCT05502237· 3. fázis· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382286· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

  NCT05458297· 2. fázis· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382299· 3. fázis· Forrás

• Fut, nem toboroz

  Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

  NCT04994717· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

  NCT04544449· 3. fázis· Forrás

• Toboroz

  EULAT Eradicate GBC

  NCT06192719· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Follikuláris limfóma2 toboroz
• Mielóma multiplex2 toboroz
• Alzheimer-kór1 toboroz
• Colitis ulcerosa1 toboroz
• Csontritkulás1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Hodgkin-limfóma1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Máj- és epeúti rák1 toboroz
• Petefészekrák1 toboroz
• Spinal cord injury1 toboroz
• Tripla negatív emlőrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Feasibility of Using Immersive Virtual Functional Rehabilitation for Recovery of Upper Extremity Function in Patients With Early-stage Stroke: a Pilot Study

  NCT07086365· Forrás

• Lezárult

  Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

  NCT05153239· 3. fázis· Forrás

• Lezárult

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)

  NCT05144841· 2. fázis· Forrás

• Lezárult

  Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

  NCT05008224· 2. fázis· Forrás

• Lezárult

  Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

  NCT03734640· Forrás

• Lezárult

  Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder Cancer

  NCT07744477· Forrás

• Lezárult

  Validation of Differential Serum Levels for Five Minerals in South American Gallstone Patients With and Without Gallbladder Cancer

  NCT07642817· Forrás

• Lezárult

  Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma

  NCT02807636· 3. fázis· Forrás

Vizsgálati helyszínek

• Clinica Alemana de Santiago1 vizsgálat
• Clínica Alemana3 vizsgálat
• Clinica Alemana de Santiago13 vizsgálat
• Clinica Alemana de Santiago /ID# 2441391 vizsgálat
• Clínica Alemana de Santiago (Site 0143)1 vizsgálat
• Clínica Alemana de Santiago (Site 0610)1 vizsgálat
• Clinica Alemana de Santiago (Site 1124)1 vizsgálat
• Clínica Alemana de Santiago (Site 1206)1 vizsgálat
• Clinica Alemana de Santiago (Site 1514)1 vizsgálat
• Clínica Alemana de Santiago (Site 1608)1 vizsgálat
• Clínica Alemana de Santiago (Site 1903)1 vizsgálat
• Clínica Alemana de Santiago (Site 2209)1 vizsgálat
• Clínica Alemana de Santiago (Site 2704)1 vizsgálat
• Department of Orthopedic Surgery, Clinica Alemana de Santiago1 vizsgálat
• Clinica Alemana3 vizsgálat